The drug "Tafen-nazal" (instruction)

This dosed nasal spray has strong antiallergic and anti-inflammatory properties. The drug "Tafen-nasal", the instruction to which indicates the need to use only therapeutic doses, does not have a resorptive effect.

The active substance of this drug is budesonide. In 1 dose of the drug contains 50 μg of this substance. A white homogeneous suspension consisting of budesonide and auxiliary substances (methyl parahydroxybenzoate, microcrystalline cellulose, propyl parahydroxybenzoate, sodium carboxymethylcellulose, simethicone-emulsion, polysorbate 80, propylene glycol, sucrose, disodium salt, hydrochloric acid and purified water) is found in a glass ball of dark glass. Each can is designed for 200 doses. It is equipped with a dosing mechanical device with a special tip-nozzle, which is very convenient to use.

In what cases is the drug "Tafen" shown? The instruction to it recommends using this spray for allergic rhinitis, inflammation of the upper respiratory organs. This drug is well tolerated and does not have corticoid activity. The drug increases the synthesis of anti-inflammatory proteins, reduces the number of mast cells and granulocytes eosinophilic. Due to budesonide, the release of toxic proteins, free radicals from macrophage cells, as well as lymphokines from lymphocytes, is reduced. In the process of drug exposure, the adhesion of molecules to endothelial cells is reduced, so the influx of leukocytes into inflamed places is greatly reduced. The drug affects the inhibition of the synthesis of leukotrienes, prostaglandins and PAF, which induce an inflammatory response.

The drug "Tafen-nasal", the instruction to which guarantees a reduction in the severity of symptoms of allergic rhinitis, effectively suppresses the early and late phases of an allergic reaction. It removes a strong inflammation of the respiratory tract. A marked improvement is observed on day 2-3.

The drug "Tafen-nasal": instructions for use

Children after 6 years and adults: at the beginning of treatment - 2 doses of 2 r. Per day (in each nostril). Supportive doses that relieve symptoms of rhinitis - 1 dose of 2 r. Per day or 2 doses of 1 p. Per day (in each nostril). A single maximum dose of 100 mcg in each nostril, a daily maximum dose of 400 mcg (course of admission - 3 months).

The full therapeutic effect of taking the drug is observed with proper and regular application. If the dose is missed, you should take it as soon as possible. Between the intervals the interval should be at least 1 hour.

Side effects: irritation of mucous throat and nose, nosebleeds, coughing, dry mouth, sneezing, rash, hives, dermatitis, dizziness, fatigue. Very rarely there are cases of angioedema, growth retardation, nasal septum perforation, tachycardia, loss of smell.

Contraindications to the use of the drug "Tafen-nasal", the instruction to which it is not allowed for children under 6 years of age, are infectious diseases of the respiratory system caused by fungi, bacteria, various viruses; pulmonary tuberculosis; Hypersensitivity to the components of the drug.

The drug "Tafen-nasal" during pregnancy is prescribed only when the benefit of the medicine for the mother exceeds the estimated harm for the unborn child. Breastfeeding stops when using a medicament during lactation.

With prolonged use of large doses, hypercorticoid symptoms may appear. When they appear, the drug is stopped taking, gradually reducing the dose. This drug from pharmacies is dispensed on prescription. The drug is stored for 2 years at room temperature.